AnaptysBio, Inc. (ANAB)
44.74
+0.94
(+2.15%)
USD |
NASDAQ |
Dec 10, 13:06
AnaptysBio EPS Diluted (Quarterly): 0.5208 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ovid Therapeutics, Inc. | -0.171 |
| Ionis Pharmaceuticals, Inc. | -0.805 |
| Vanda Pharmaceuticals, Inc. | -0.3822 |
| CorMedix, Inc. | 1.259 |
| Verastem, Inc. | -1.347 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 15.11M |
| Revenue (Quarterly) | 76.32M |
| Total Expenses (Quarterly) | 61.21M |
| Enterprise Value | 1.310B |
| Gross Profit Margin (Quarterly) | 99.20% |
| Profit Margin (Quarterly) | 19.80% |
| Earnings Yield | -6.30% |
| Normalized Earnings Yield | -6.301 |